FIELD: medicine.
SUBSTANCE: invention relates to ophthalmologic agent composition containing therapeutically active component, namely 5-bromo-6-(2-imidazolin-2-yl-amino)-quinoxaline, solubility-increasing components except for cyclodextrins, and chloroxy derivatives, preferably effective as conserving agents. Chloroxy derivatives are preferable for conserving of therapeutically active components. Solubility-increasing components includes carboxymethyl cellulose.
EFFECT: improves composition for ophthalmology.
6 cl, 7 tbl, 1 dwg, 3 ex
Authors
Dates
2007-01-20—Published
2001-07-09—Filed